Cargando…
Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation
Deregulation of chromatin modifiers plays an essential role in the pathogenesis of medulloblastoma, the most common paediatric malignant brain tumour. Here, we identify a BMI1-dependent sensitivity to deregulation of inositol metabolism in a proportion of medulloblastoma. We demonstrate mTOR pathway...
Autores principales: | Badodi, Sara, Pomella, Nicola, Zhang, Xinyu, Rosser, Gabriel, Whittingham, John, Niklison-Chirou, Maria Victoria, Lim, Yau Mun, Brandner, Sebastian, Morrison, Gillian, Pollard, Steven M., Bennett, Christopher D., Clifford, Steven C., Peet, Andrew, Basson, M. Albert, Marino, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042111/ https://www.ncbi.nlm.nih.gov/pubmed/33846320 http://dx.doi.org/10.1038/s41467-021-22379-7 |
Ejemplares similares
-
EMBR-10. INOSITOL TREATMENT INHIBITS MEDULLOBLASTOMA THROUGH SUPPRESSION OF EPIGENETIC-DRIVEN METABOLIC ADAPTATION
por: Badodi, Sara, et al.
Publicado: (2021) -
Combination of BMI1 and MAPK/ERK inhibitors is effective in medulloblastoma
por: Badodi, Sara, et al.
Publicado: (2022) -
MEDB-23. Targeting epigenetic dysregulation in medulloblastoma with poor prognosis
por: Badodi, Sara, et al.
Publicado: (2022) -
Glutamine metabolism, the Achilles heel for medulloblastoma tumor
por: Niklison-Chirou, Maria Victoria
Publicado: (2018) -
NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma
por: Frisira, Eleni, et al.
Publicado: (2019)